You just read:

Forge Therapeutics Enters Into a Pilot Study with Janssen Research & Development, LLC, to Discover Novel Metalloprotein Inhibitors

News provided by

Forge Therapeutics, Inc.

Jul 21, 2015, 08:00 ET